Answers are grounded in this paper and cite their sources.
Systematic review explores ECMO's impact on cardiopulmonary dysfunction in rheumatologic diseases, indicating potential survival benefits.
ECMO remains a potential option in life-threatening rheumatologic disease complications. In this review, 416 patients recovered due to ECMO who likely would not have otherwise survived. However, available evidence is largely limited to case reports and small retrospective studies. Limitations include small sample sizes and heterogeneity in reported data.
No takes yet. Share an insight, caveat, or question.
Falaas et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: